1 |
Lee CI, Chou AK, Lin CC, et al. Immune and inflammatory gene signature in rat cerebrum in subarachnoid hemorrhage with microarray analysis[J]. Mol Med Rep, 2012, 5 (1): 118-125.
|
2 |
Ayer RE, Ostrowski RP, Sugawara T, et al. Statin-induced T-lymphocyte modulation and neuroprotection following experimental subarachnoid hemorrhage[J]. Acta Neurochir Suppl, 2013 (115): 259-266.
|
3 |
李肖亮,单爱军,杜波,等. 急危重症患者继发性脑损伤救治中脑保护的研究进展[J/CD]. 中华危重症医学杂志(电子版),2011,4(1):47-52.
|
4 |
Pitman MR, Woodcock JM, Lopez AF, et al. Molecular targets of FTY720 (fingolimod)[J]. Curr Mol Med, 2012, 12 (10): 1207-1219.
|
5 |
White C, Alshaker H, Cooper C, et al. The emerging role of FTY720 (Fingolimod) in cancer treatment[J]. Oncotarget, 2016, 7 (17): 23106-23127.
|
6 |
Natarajan V, Dudek SM, Jacobson JR, et al. Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury [J]. Am J Respir Cell Mol Biol, 2013, 49 (1): 6-17.
|
7 |
Patmanathan SN, Yap LF, Murray PG, et al. The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod[J]. J Cell Mol Med, 2015, 19 (10): 2329-2340.
|
8 |
Zhang L, Wang HD, Ji XJ, et al. FTY720 for cancer therapy (Review)[J]. Oncol Rep, 2013, 30 (6): 2571-2578.
|
9 |
Estella-Hermoso de Mendoza A, Castello-Cros R, Imbuluzqueta E, et al. Lipid nanosystems enhance the bioavailability and the therapeutic efficacy of FTY720 in acute myeloid leukemia[J]. J Biomed Nanotechnol, 2015, 11 (4): 691-701.
|
10 |
Yoshida Y, Tsuji T, Watanabe S, et al. Efficacy of combination treatment with fingolimod (FTY720) plus pathogenic autoantigen in a glucose-6-phosphate isomerase peptide (GPI325-339)-induced arthritis mouse model [J]. Biol Pharm Bull, 2013, 36 (11): 1739-1746.
|
11 |
Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory[J]. Nat Protoc, 2006, 1 (2): 848-858.
|
12 |
Fujii M, Yan J, Rolland WB, et al. Early brain injury, an evolving frontier in subarachnoid hemorrhage research [J]. Transl Stroke Res, 2013, 4 (4): 432-446.
|
13 |
Yuksel S, Tosun YB, Cahill J, et al. Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis[J]. Turk Neurosurg, 2012, 22 (5): 529-533.
|
14 |
Rolland WB 2nd, Manaenko A, Lekic T, et al. FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice[J]. Acta Neurochir Suppl, 2011 (111): 213-217.
|
15 |
Hasegawa Y, Suzuki H, Sozen T, et al. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats[J]. Stroke, 2010, 41 (2): 368-374.
|
16 |
Serrone JC, Maekawa H, Tjahjadi M, et al. Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions[J]. Expert Rev Neurother, 2015, 15 (4): 367-380.
|
17 |
Tso MK, Macdonald RL. Subarachnoid hemorrhage: a review of experimental studies on the microcirculation and the neurovascular unit[J]. Transl Stroke Res, 2014, 5 (2): 174-189.
|
18 |
Wan H, AlHarbi BM, Macdonald RL. Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage[J]. Expert Opin Pharmacother, 2014, 15 (2): 231-243.
|
19 |
Janssen S, Schlegel C, Gudi V, et al. Effect of FTY720-phosphate on the expression of inflammation-associated molecules in astrocytes in vitro[J]. Mol Med Rep, 2015, 12 (4): 6171-6177.
|
20 |
Zhang Z, Zhang Z, Fauser U, et al. FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury [J]. J Cell Mol Med, 2007, 11 (2): 307-314.
|
21 |
Rolland WB, Lekic T, Krafft PR, et al. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage[J]. Exp Neurol, 2013 (241): 45-55.
|